Investors in big pharma, biotech look to ride out Trump storm
January 12, 2017 at 15:22 PM EST
NEW YORK, Jan 12 (Reuters) - Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of political uncertainty as the incoming Trump administration dives into healthcare policy.
